5-Methylimidazo[1,5-a]pyridine-6-carboxylic acid, 95%, 500mg

4-Sulfamoylbenzoic Acid>95.0%(T)500g

3-Bromo-N,N-dimethylpyridin-4-amine, 95.0%, 250mg

(3-((3-(trifluoromethyl)phenyl)carbamoyl)phenyl)boronic acid, 95+%, 250mg

2,4-Difluorophenylacetic acid, 97.0%, 1g

Methyl 3-methyl-1H-pyrrole-2-carboxylate, 95.0%, 10g

H-Tyr-NH2 HCl, 95.0%, 5g

2-Iodobenzaldehyde>98.0%(GC)1g

Escualeno, mínimo 90 %, para síntesis, 100 ml, envase de vidrio

(2R)-1-BOC-2-PROPYLPYRROLIDINE-2-METHANAMINE, 95.0%, 1g

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyldimethylsilyl)-L-homoserine, 97%, 1g

2-Cyano-N-(2-hydroxyethyl)acetamide, 97.0%, 2.5g

4-CHLORO-5-IODO-7-ISOPROPYL-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 25g